Literature DB >> 21994054

Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome.

Jaume Mora1, Eva Rodríguez, Carmen de Torres, Teresa Cardesa, José Ríos, Teresa Hernández, Antonio Cardesa, Enrique de Alava.   

Abstract

BACKGROUND: In Ewing sarcoma (EWS) most of the research on signaling pathways has been performed on cell lines or animal models. The objective of the current study was to determine the relation between clinical outcome and the expression of proteins involved in active growth signaling pathways.
METHODS: A paraffin-embedded microarray of 45 human primary EWS tissue specimens was stained with the antibodies against c-KIT, AKT, p-AKT, p-mTOR, IGF-1R, IGFBP-3, MAPK, p27(KIP1) , and p70S6 kinase. Immunohistochemical staining was correlated with patient overall survival (OS).
RESULTS: In the univariate analysis 3 variables showed statistical significance to predict survival: presence of metastasis, p-mTOR, and p27(KIP1). A positive stain for p-mTOR (hazard ratio of 4.74 [95% CI (57, 121)]) was significantly (log-rank test with a P = 0.029) associated with better OS. Also, a positive stain for p27(KIP1) (hazard ratio of 6.87 [95% CI (77, 136)] was significantly (log-rank test with a P = 0.009) associated with better OS. Multivariate analysis showed metastasis (HR: 4.3; 95% CI: 0.99, 19; P = 0.05), p-mTOR (HR: 4.8 with 95% CI: 0.6, 38; P = 0.13) and p27 (HR: 5.3; 95% CI: 1.37, 20; P = 0.01) as independent prognostic factors of outcome.
CONCLUSIONS: In our series, p-mTOR and p27(KIP1) protein overexpression were independently associated with better survival.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21994054     DOI: 10.1002/pbc.23348

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  11 in total

1.  Prognostic and therapeutic relevance of the IGF pathway in Ewing's sarcoma patients.

Authors:  A C M van de Luijtgaarden; Y M H Versleijen-Jonkers; M H S Roeffen; H W B Schreuder; U E Flucke; W T A van der Graaf
Journal:  Target Oncol       Date:  2013-01-06       Impact factor: 4.493

2.  Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin.

Authors:  Lara Grande; Gabriel Bretones; Manuel Rosa-Garrido; Eva M Garrido-Martin; Teresa Hernandez; Susana Fraile; Luisa Botella; Enrique de Alava; August Vidal; Xavier Garcia del Muro; Alberto Villanueva; M Dolores Delgado; Jose L Fernandez-Luna
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

3.  Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression.

Authors:  Yongqing Liu; Ester Sánchez-Tilló; Xiaoqin Lu; Li Huang; Brian Clem; Sucheta Telang; Alfred B Jenson; Miriam Cuatrecasas; Jason Chesney; Antonio Postigo; Douglas C Dean
Journal:  J Biol Chem       Date:  2013-02-26       Impact factor: 5.157

4.  Targeted therapies for bone sarcomas.

Authors:  Dominique Heymann; Françoise Rédini
Journal:  Bonekey Rep       Date:  2013-07-17

5.  Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma.

Authors:  Mark A Applebaum; Dafydd G Thomas; Todd Hembrough; Jon Burrows; Andrew E Horvai; Elizabeth R Lawlor; Steven G DuBois
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-09

6.  Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis.

Authors:  Junbo Liang; Binghao Li; Li Yuan; Zhaoming Ye
Journal:  Onco Targets Ther       Date:  2015-07-29       Impact factor: 4.147

7.  Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway.

Authors:  Laura Lagares-Tena; Silvia García-Monclús; Roser López-Alemany; Olga Almacellas-Rabaiget; Juan Huertas-Martínez; Miguel Sáinz-Jaspeado; Silvia Mateo-Lozano; Carlos Rodríguez-Galindo; Santiago Rello-Varona; David Herrero-Martín; Oscar M Tirado
Journal:  Oncotarget       Date:  2016-08-30

Review 8.  Metabolic landscapes in sarcomas.

Authors:  Richard Miallot; Franck Galland; Virginie Millet; Jean-Yves Blay; Philippe Naquet
Journal:  J Hematol Oncol       Date:  2021-07-22       Impact factor: 17.388

9.  Bone sarcomas: from biology to targeted therapies.

Authors:  Nathalie Gaspar; Angela Di Giannatale; Birgit Geoerger; Françoise Redini; Nadège Corradini; Natacha Enz-Werle; Franck Tirode; Perrine Marec-Berard; Jean-Claude Gentet; Valérie Laurence; Sophie Piperno-Neumann; Odile Oberlin; Laurence Brugieres
Journal:  Sarcoma       Date:  2012-11-27

10.  Akt and Hippo Pathways in Ewing's Sarcoma Tumors and Their Prognostic Significance.

Authors:  Atif A Ahmed; Malak Abedalthagafi; Ahmed E Anwar; Marilyn M Bui
Journal:  J Cancer       Date:  2015-08-22       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.